Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$907M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$644M |
| 4 |
NVIDIA
NVDA
|
+$440M |
| 5 |
CRH
CRH
|
+$429M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$689M |
| 2 |
Home Depot
HD
|
+$377M |
| 3 |
Cigna
CI
|
+$322M |
| 4 |
Valero Energy
VLO
|
+$250M |
| 5 |
Amphenol
APH
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.35% |
| 2 | Technology | 9.23% |
| 3 | Healthcare | 7.6% |
| 4 | Financials | 5.15% |
| 5 | Consumer Discretionary | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
CALL
Olin
OLN
$1.95B
| $1.67M | ﹤0.01% |
+33,400
| New | +$1.8M |
|
3652
CALL
Harmony Biosciences
HRMY
$2.28B
| $1.66M | ﹤0.01% |
50,800
-10,300
| -17% | -$358K |
|
3653
Kura Oncology
KURA
$1.13B
| $1.66M | ﹤0.01% |
182,430
-213,741
| -54% | -$2.17M |
|
|
ESGR
3654
DELISTED
Enstar Group
ESGR
| $1.66M | ﹤0.01% |
6,872
+5,686
| +479% | +$1.43M |
|
3655
CALL
Tandem Diabetes Care
TNDM
$1.49B
| $1.66M | ﹤0.01% |
80,000
+60,000
| +300% | +$1.65M |
|
3656
Green Dot
GDOT
$760M
| $1.66M | ﹤0.01% |
119,160
+4,083
| +4% | +$67.3K |
|
3657
Daktronics
DAKT
$932M
| $1.66M | ﹤0.01% |
185,949
-310,317
| -63% | -$2.45M |
|
3658
PUT
STMicroelectronics
STM
$44B
| $1.66M | ﹤0.01% |
38,400
+26,500
| +223% | +$1.26M |
|
3659
CALL
Alcoa
AA
$13.3B
| $1.66M | ﹤0.01% |
57,000
+10,400
| +22% | +$326K |
|
3660
PUT
AerCap
AER
$23.2B
| $1.65M | ﹤0.01% |
+26,400
| New | +$1.66M |
|
3661
FirstService
FSV
$6.18B
| $1.65M | ﹤0.01% |
11,345
-47,123
| -81% | -$7.2M |
|
3662
eGain
EGAN
$203M
| $1.65M | ﹤0.01% |
269,050
+154,248
| +134% | +$1.04M |
|
3663
Cognyte Software
CGNT
$650M
| $1.65M | ﹤0.01% |
342,837
-320,501
| -48% | -$1.63M |
|
3664
PUT
Jack Henry & Associates
JKHY
$12.1B
| $1.65M | ﹤0.01% |
10,900
+600
| +6% | +$96.8K |
|
3665
CALL
Biomea Fusion
BMEA
$125M
| $1.65M | ﹤0.01% |
119,600
+101,400
| +557% | +$1.83M |
|
|
3666
CALL
STMicroelectronics
STM
$44B
| $1.64M | ﹤0.01% |
+38,100
| New | +$1.82M |
|
3667
SFL Corp
SFL
$1.72B
| $1.64M | ﹤0.01% |
147,463
+49,931
| +51% | +$517K |
|
3668
Park National Corp
PRK
$3.58B
| $1.64M | ﹤0.01% |
17,393
-1,606
| -8% | -$166K |
|
3669
CALL
Transmedics
TMDX
$3.07B
| $1.64M | ﹤0.01% |
30,000
+20,000
| +200% | +$1.44M |
|
3670
Viasat
VSAT
$9.28B
| $1.64M | ﹤0.01% |
88,972
+61,815
| +228% | +$1.77M |
|
3671
Arcutis Biotherapeutics
ARQT
$2.99B
| $1.64M | ﹤0.01% |
+308,949
| New | +$2.63M |
|
|
SLNO
3672
DELISTED
Soleno Therapeutics
SLNO
| $1.64M | ﹤0.01% |
+55,456
| New | +$336K |
|
|
ETNB
3673
DELISTED
89bio
ETNB
| $1.63M | ﹤0.01% |
105,853
-214,297
| -67% | -$3.6M |
|
|
GLDD
3674
DELISTED
Great Lakes Dredge & Dock
GLDD
| $1.63M | ﹤0.01% |
204,589
-62,747
| -23% | -$520K |
|
3675
iShares Core MSCI Total International Stock ETF
IXUS
$60.8B
| $1.63M | ﹤0.01% |
+27,171
| New | +$1.69M |
|
Similar funds
Israel Englander's Q3 2023 Portfolio in Review
As of Q3 2023, Israel Englander held 6,895 positions worth $198B, down 2.3% from $203B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Israel Englander deployed $6.14B of net new capital in Q3 2023, opening 836 new positions and adding to 2,326 existing holdings. Its largest new stake was Mobileye: 2,953,164 shares worth $123M.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 56% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $689M trimmed.
- Israel Englander's largest Q3 2023 buy was Mobileye: 2,953,164 shares worth $123M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.7B increase.
- Israel Englander's biggest Q3 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $689M.
- Israel Englander fully exited Blackstone in Q3 2023, selling an estimated $178M.
- Israel Englander's ten largest holdings make up 21% of its $198B portfolio in Q3 2023.
- Israel Englander opened 836 new positions and closed 834 in Q3 2023.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $198B.
Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.